This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Jun;2(6):284-5.

doi: 10.1038/ncponc0165.

Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?

José Baselga¹

Affiliations

PMID: 16264980
DOI: 10.1038/ncponc0165

Comment

Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?

José Baselga. Nat Clin Pract Oncol. 2005 Jun.

. 2005 Jun;2(6):284-5.

doi: 10.1038/ncponc0165.

Author

José Baselga¹

Affiliation

¹ Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

PMID: 16264980
DOI: 10.1038/ncponc0165

No abstract available

PubMed Disclaimer

Comment on

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB. Chung KY, et al. J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program